CGA
Crescent Grove Advisors’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
+2,388
| New | +$208K | 0.02% | 270 |
|
|
2025
Q1 | – | Sell |
-2,667
| Closed | -$207K | – | 272 |
|
|
2024
Q4 | $207K | Buy |
+2,667
| New | +$207K | 0.02% | 265 |
|
|
2024
Q3 | – | Sell |
-2,193
| Closed | -$249K | – | 283 |
|
|
2024
Q2 | $249K | Buy |
+2,193
| New | +$249K | 0.03% | 239 |
|
|
2023
Q3 | – | Sell |
-2,002
| Closed | -$257K | – | 285 |
|
|
2023
Q2 | $257K | Buy |
+2,002
| New | +$257K | 0.03% | 247 |
|
|
2022
Q2 | – | Sell |
-460
| Closed | -$235K | – | 273 |
|
|
2022
Q1 | $235K | Hold |
460
| – | – | 0.02% | 262 |
|
|
2021
Q4 | $247K | Buy |
+460
| New | +$247K | 0.02% | 258 |
|